Orchid Receives US Approval for Cystic Fibrosis Diagnostic Kit | GenomeWeb

NEW YORK, Aug 16 – Orchid BioSciences said Thursday it had received approval to provide its cystic fibrosis genetic screening test to certain approved labs in the United States.

The Elucigene CF 29 test screens for 29 common mutations associated with cystic fibrosis and includes the 25 mutations the American College of Medical Genetics recommends for cystic fibrosis testing.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."